A groundbreaking study led by University of Texas researchers demonstrates that Obeldesivir, an oral form of Remdesivir, successfully protected monkeys infected with high doses of the Ebola virus.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.